There were 1,129 press releases posted in the last 24 hours and 441,674 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Inventiva annonce la reprise du screening dans l’étude clinique de Phase III, NATiV3, évaluant lanifibranor dans la NASH  

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image